LeMaitre Vascular Inc
NASDAQ:LMAT
LeMaitre Vascular Inc
Net Change in Cash
LeMaitre Vascular Inc
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LeMaitre Vascular Inc
NASDAQ:LMAT
|
Net Change in Cash
$9.9m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Becton Dickinson and Co
NYSE:BDX
|
Net Change in Cash
$326m
|
CAGR 3-Years
-39%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Boston Scientific Corp
NYSE:BSX
|
Net Change in Cash
$1.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Stryker Corp
NYSE:SYK
|
Net Change in Cash
$659m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbott Laboratories
NYSE:ABT
|
Net Change in Cash
-$2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-28%
|
CAGR 10-Years
-2%
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Net Change in Cash
$701.3m
|
CAGR 3-Years
58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
See Also
What is LeMaitre Vascular Inc's Net Change in Cash?
Net Change in Cash
9.9m
USD
Based on the financial report for Mar 31, 2024, LeMaitre Vascular Inc's Net Change in Cash amounts to 9.9m USD.
What is LeMaitre Vascular Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 3Y
-8%
Over the last year, the Net Change in Cash growth was 778%. The average annual Net Change in Cash growth rates for LeMaitre Vascular Inc have been -8% over the past three years .